MDMA ecstasy-induced serotonin loss; Implications for depressive and anxiety disorders

被引：0
|
作者：
Harkin, A. [1 ]
机构：
[1] Univ Dublin Trinity Coll, Inst Neurosci, Dublin 2, Ireland
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2008年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：14 / 14
页数：1
相关论文
共 50 条
  • [1] Reversibility of ecstasy-induced reduction in serotonin transporter availability in polydrug ecstasy users
    Buchert, R
    Thomasius, R
    Petersen, K
    Wilke, F
    Obrocki, J
    Nebeling, B
    Wartberg, L
    Zapletalova, P
    Clausen, M
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (02) : 188 - 199
  • [2] Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in rats
    Durkin, Sarah
    Prendergast, Alison
    Harkin, Andrew
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (08): : 1894 - 1901
  • [3] Neuropsychiatric disorders induced by MDMA ("ecstasy")
    Bailly, D
    [J]. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 1999, 25 (06): : 595 - 602
  • [4] MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment
    Christopher D. Verrico
    Gregory M. Miller
    Bertha K. Madras
    [J]. Psychopharmacology, 2007, 189 : 489 - 503
  • [5] MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment
    Verrico, Christopher D.
    Miller, Gregory M.
    Madras, Bertha K.
    [J]. PSYCHOPHARMACOLOGY, 2007, 189 (04) : 489 - 503
  • [6] Reversibility of ecstasy-induced reduction in serotonin transporter availability in polydrug ecstasy users
    Ralph Buchert
    Rainer Thomasius
    Kay Petersen
    Florian Wilke
    Jost Obrocki
    Bruno Nebeling
    Lutz Wartberg
    Pavlina Zapletalova
    Malte Clausen
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2006, 33 : 188 - 199
  • [7] Ecstasy-induced optic disc swelling and consequent visual loss
    Ramsauer, Michaela
    Thurau, Stephan
    Priglinger, Siegfried
    Vounotrypidis, Efstathios
    [J]. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2020, 13 (03) : 520 - 522
  • [8] Ecstasy-induced optic disc swelling and consequent visual loss
    Michaela Ramsauer
    Stephan Thurau
    Siegfried Priglinger
    Efstathios Vounotrypidis
    [J]. International Journal of Ophthalmology, 2020, (03) : 520 - 522
  • [9] How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale
    Johansen, P. O.
    Krebs, T. S.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2009, 23 (04) : 389 - 391
  • [10] Chronic Fluoxetine Treatment Partly Attenuates the Long-Term Anxiety and Depressive Symptoms Induced by MDMA (‘Ecstasy’) in Rats
    Murray R Thompson
    Kong M Li
    Kelly J Clemens
    Clint G Gurtman
    Glenn E Hunt
    Jennifer L Cornish
    Iain S McGregor
    [J]. Neuropsychopharmacology, 2004, 29 : 694 - 704
12345